Vitamin K for prevention and treatment of skin rash secondary to anti-EGFR therapy

Details for Australian Patent Application No. 2006236633 (hide)

Owner Albert Einstein College of Medicine of Yeshiva University

Inventors Ling, Yi-He; Perez-Soler, Roman

Agent FB Rice

Pub. Number AU-B-2006236633

PCT Pub. Number WO2006/113479

Priority 60/671,563 15.04.05 US

Filing date 12 April 2006

Wipo publication date 26 October 2006

Acceptance publication date 29 March 2012

International Classifications

A61K 33/24 (2006.01) Medicinal preparations containing inorganic active ingredients - Heavy metals

Event Publications

18 October 2007 PCT application entered the National Phase

  PCT publication WO2006/113479 Priority application(s): WO2006/113479

29 March 2012 Application Accepted

  Published as AU-B-2006236633

26 July 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006236637-Methods and compositions for treating or preventing cancer

2006236629-Methods and compositions to modulate adhesion and stress tolerance in bacteria